Ronald W Eastman's Net Worth

$19.7 Thousand

Estimate Recalculated Sep 8, 2024 07:35PM EST

Who is Ronald W Eastman?

Ronald W Eastman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Corium International, Inc., Revance Therapeutics, Inc., Bioventus Inc., pSivida Corp., BioPlus Acquisition Corp., and Epiphany Technology Acquisition Corp..

SEC CIK

Ronald W Eastman's CIK is 0001597585

Past Insider Trading and Trends

2017 was Ronald W Eastman's most active year for acquiring shares with 3 total transactions. Ronald W Eastman's most active month to acquire stocks was the month of April. 2018 was Ronald W Eastman's most active year for disposing of shares, totalling 3 transactions. Ronald W Eastman's most active month to dispose stocks was the month of October. 2015 saw Ronald W Eastman paying a total of $0.00 for 28,000 shares, this is the most they've acquired in one year. In 2018 Ronald W Eastman cashed out on 50,000 shares for a total of $625,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Corium International, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-9.35M
$12.50
-$116,916,300.00
0
Nov 27
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Dec 18
Form 4
∞
9.35M
$8.00
—
9.35M
Apr 8
Form 3
—
0
—
—
0
No matching records found

Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56

Investor

Ronald W Eastman owns 3,000 units of Common Stock which is worth $19,680.00.acquired a total of 3,000 shares in Revance Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3K
—
—
3K
May 11
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
Apr 8
Form 4
∞
4.13M
—
—
4.13M
Feb 11
Form 3
—
0
—
—
0
No matching records found

Bioventus Inc. (BVS) Snapshot price: $9.54

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

pSivida Corp. (EYPT) Snapshot price: $7.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

BioPlus Acquisition Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found